<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>DSpace Collection: Thesis - Experimental Pharmacology</title>
    <link>http://etd.aau.edu.et:80/dspace/handle/123456789/414</link>
    <description />
    <textInput>
      <title>The Collection's search engine</title>
      <description>Search the Channel</description>
      <name>search</name>
      <link>http://etd.aau.edu.et:80/dspace/simple-search</link>
    </textInput>
    <item>
      <title>GASTROINTESTINAL EFFECTS OF CRUDE KHAT (CATHA EDULIS  F) EXTRACT FOLLOWING ACUTE AND SUB-CHRONIC ADMINISTRATION IN RODENTS</title>
      <link>http://etd.aau.edu.et:80/dspace/handle/123456789/3065</link>
      <description>Title: GASTROINTESTINAL EFFECTS OF CRUDE KHAT (CATHA EDULIS  F) EXTRACT FOLLOWING ACUTE AND SUB-CHRONIC ADMINISTRATION IN RODENTS
&lt;br/&gt;
&lt;br/&gt;Authors: WINTANA, TADESSE
&lt;br/&gt;
&lt;br/&gt;Abstract: Khat (Catha edulis F) belongs to the Celastraceae family and is a dicotyledonous&#xD;
evergreen shrub/tree used for recreation and alleviation of fatigue in several countries of&#xD;
East Africa and South Arabia. Recently, this habit has spread considerably, raising&#xD;
concern in view of medical and socio-economic consequences of khat consumption. Even&#xD;
though khat has several medicinal, social, and economical values, there are numerous&#xD;
reports regarding its gastrointestinal tract (GIT) adverse effects. As the effects of khat&#xD;
chewing on digestive system mentioned in earlier studies were based on clinical&#xD;
observations, the present study was designed to evaluate the GIT activity of the crude&#xD;
khat extract after acute and sub-chronic administration using different rodent models and&#xD;
parameters used for ulcer and motility measurement were quantified.&#xD;
For acute study, animals were randomly assigned into different groups. Negative control&#xD;
received Tween 80 2% in distilled water, whereas positive controls were given ranitidine&#xD;
(pylorus ligation and cysteamine HCl models), misoprostol (indomethacin induced&#xD;
gastric ulcer), and loperamide (castor oil induced diarrhea and enteropooling assay). The&#xD;
other group received different doses of crude khat extract: 100 mg/kg, 200 mg/kg and&#xD;
300 mg/kg. For sub-chronic study, one group was administered vehicle and served as&#xD;
control, whilst the other three were administered three doses of khat extract (100, 200,&#xD;
and 300 mg/kg) for 45 days.&#xD;
Acute khat administration in pylorus ligation model was shown to aggravate ulcer&#xD;
compared to controls in the highest dose used, as evidenced by increased volume of&#xD;
gastric acid secretion (p&lt;0.05), total acidity (p&lt;0.05) and ulcer index (p&lt;0.01). Similar&#xD;
results were obtained in indomethacin induced gastric ulcer model where 300 mg/kg khat&#xD;
extract increased mucosal damage as demonstrated by a significant reduction in mucin&#xD;
content compared with misoprostol (p&lt;0.001) and vehicle (p&lt;0.05) treated animals. Khat&#xD;
at 300 mg/kg was also shown to accentuate duodenal ulcer induced by cysteamine HCl&#xD;
by significantly increasing (p&lt;0.01) ulcer area as compared to vehicle-treated rats. Whilst&#xD;
ranitidine was shown to offer antiulcer activity in the models tested, khat at 100 mg/kg&#xD;
was devoid of any significant ameliorating or accentuating effect. Surprisingly, subviii&#xD;
chronic administration of khat at all doses failed to produce neither gastric nor duodenal&#xD;
ulcer.&#xD;
In castor oil induced diarrhea, 300 mg/kg (p&lt;0.001) and 100 mg/kg (p&lt;0.01) khat&#xD;
extracts significantly decreased the number of watery fecal discharge against vehicle&#xD;
treated rats. In addition, 300 mg/kg dose decreased (p&lt;0.05) weight and volume of&#xD;
intestinal content in castor oil induced enteropooling model. In sub-chronic studies, 300&#xD;
mg/kg and 200 mg/kg khat extracts significantly inhibited intestinal motility in in-vivo&#xD;
gastrointestinal motility model by 53.2% and 48.6%, respectively. On the other hand,&#xD;
weight change on sub-chronic khat extract administration was observed and the change&#xD;
became significant at the 3rd (p&lt;0.05), 4th and 5th week (p&lt;0.01), and 6th week (p&lt;0.001)&#xD;
with 300 mg/kg dose. While in 200 mg/kg decline of weight at 4th week (p&lt;0.05) and for&#xD;
following weeks (p&lt;0.01) was obtained.&#xD;
In conclusion, acute use of khat at higher dose in the presence of ulcerogenic agents&#xD;
could aggravate gastric and duodenal ulcer, while sub-chronic khat administration alone&#xD;
did not produce ulcer. Furthermore, acute and sub-chronic administration of khat extract&#xD;
at higher dose produced a significant constipating activity. And sub-chronic&#xD;
administration of khat extract at higher dose markedly decreased body weight. These&#xD;
effects collectively indicate that khat consumption in large amount and for a longer&#xD;
period of time is associated with adverse GIT outcomes.</description>
      <pubDate>Tue, 15 May 2012 08:03:07 GMT</pubDate>
    </item>
  </channel>
</rss>

